首页 > 最新文献

Behavioral neuropsychiatry最新文献

英文 中文
Centration-distortion error: a criterion of perceptual dysfunction. 中心扭曲误差:知觉功能障碍的一个标准。
Pub Date : 1974-04-01
V Mecke

This was a study to determine whether centration, as a perceptual process, could be a criterion for differentiating between neurologically impaired and emotionally disturbed children. Centration was defined by Piaget as a prolonged involuntary attachment of a sensory modality to one part of a field, causing perceptual errors of exaggerations and distortions. It is hypothesized that centration would affect motor behavior, producing effects on drawing tasks characterized by separation of designs or their parts, coincident with distortions of the figures drawn. The neurologically impaired children were identified as having primary difficulties with perception whereas the emotionally disturbed children would have primary difficulties with intellection. The centration-distortion error would characterize the drawing of the neurologically impaired but not those of the emotionally disturbed children. A sample of 44 children was selected, each with EEG records, psychological tests and psychiatric interviews used as differential criteria for the groups. Eleven children were diagnosed as having minimal brain damage, 33 as emotionally disturbed. Three psychologists scored the Bender Gestalt tests, blind, for indicators of brain injury and emotional disturbance as defined by Koppitz' criteria, and for the centration-distortion error. The hypothesis was upheld at the .001 level of confidence, validating an earlier pilot study.

这是一项研究,以确定是否集中,作为一个知觉过程,可以作为一个标准,以区分神经受损和情绪紊乱的儿童。皮亚杰将集中定义为一种感官形态对某一领域的一部分的长期不自觉的依恋,导致夸大和扭曲的感知错误。假设集中会影响运动行为,对以分离设计或其部分为特征的绘图任务产生影响,并与绘制的图形扭曲相一致。神经障碍儿童主要表现为知觉困难,而情绪障碍儿童主要表现为思维困难。集中扭曲误差是神经受损儿童的特征,而不是情绪紊乱儿童的特征。选取了44名儿童作为样本,每个儿童都有脑电图记录、心理测试和精神病学访谈作为不同组的不同标准。11名儿童被诊断为轻度脑损伤,33名被诊断为情绪紊乱。三名心理学家对本德尔格式塔测试进行盲测,根据科皮茨标准对脑损伤和情绪障碍的指标进行评分,并对集中扭曲误差进行评分。该假设在0.001的置信度水平上得到支持,验证了早期的试点研究。
{"title":"Centration-distortion error: a criterion of perceptual dysfunction.","authors":"V Mecke","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This was a study to determine whether centration, as a perceptual process, could be a criterion for differentiating between neurologically impaired and emotionally disturbed children. Centration was defined by Piaget as a prolonged involuntary attachment of a sensory modality to one part of a field, causing perceptual errors of exaggerations and distortions. It is hypothesized that centration would affect motor behavior, producing effects on drawing tasks characterized by separation of designs or their parts, coincident with distortions of the figures drawn. The neurologically impaired children were identified as having primary difficulties with perception whereas the emotionally disturbed children would have primary difficulties with intellection. The centration-distortion error would characterize the drawing of the neurologically impaired but not those of the emotionally disturbed children. A sample of 44 children was selected, each with EEG records, psychological tests and psychiatric interviews used as differential criteria for the groups. Eleven children were diagnosed as having minimal brain damage, 33 as emotionally disturbed. Three psychologists scored the Bender Gestalt tests, blind, for indicators of brain injury and emotional disturbance as defined by Koppitz' criteria, and for the centration-distortion error. The hypothesis was upheld at the .001 level of confidence, validating an earlier pilot study.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"31-5"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15569760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthesiologic considerations in psychiatric convulsive therapy. 精神科惊厥治疗中的麻醉注意事项。
Pub Date : 1974-04-01
S Dell'Aria, W Karliner

The authors, drawing from their very large experience, describe technics of administering anesthesia and muscle-relaxing agents for convulsive therapy. After a brief historical review, they mention in detail the materials used and the set up for this modified electroconvulsive treatment. They describe the signs of amnesia and those of muscular relaxation in order to administer a modified electroconvulsive treatment properly. A comparison of this modification with various other methods used in different centers is made. A section of the paper is devoted to the less common use of Indoklon. Contraindications for the various therapeutic methods are mentioned and a critical evaluation is provided. The authors draw conclusions from their clinical experience and give the results of their observations. The management of various side-effects and possible complications is discussed. The article should be considered as a guide in the use of modified convulsive therapy.

作者根据他们丰富的经验,描述了痉挛治疗中麻醉和肌肉松弛剂的使用技术。在简短的历史回顾之后,他们详细地提到了使用的材料和这种改进的电休克治疗的设置。他们描述了健忘症和肌肉松弛的症状,以便适当地实施改良的电休克治疗。并与不同中心使用的各种其他方法进行了比较。这篇文章有一节专门介绍了不太常用的印克朗语。各种治疗方法的禁忌症被提及,并提供了一个关键的评价。作者从他们的临床经验中得出结论,并给出了他们观察的结果。讨论了各种副作用和可能的并发症的处理。这篇文章应该被认为是使用改良抽搐疗法的指南。
{"title":"Anesthesiologic considerations in psychiatric convulsive therapy.","authors":"S Dell'Aria,&nbsp;W Karliner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The authors, drawing from their very large experience, describe technics of administering anesthesia and muscle-relaxing agents for convulsive therapy. After a brief historical review, they mention in detail the materials used and the set up for this modified electroconvulsive treatment. They describe the signs of amnesia and those of muscular relaxation in order to administer a modified electroconvulsive treatment properly. A comparison of this modification with various other methods used in different centers is made. A section of the paper is devoted to the less common use of Indoklon. Contraindications for the various therapeutic methods are mentioned and a critical evaluation is provided. The authors draw conclusions from their clinical experience and give the results of their observations. The management of various side-effects and possible complications is discussed. The article should be considered as a guide in the use of modified convulsive therapy.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"6-17"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15569763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged progestin (quingestanol) therapy of menopausal diabetic women. 延长黄体酮(青estanol)治疗绝经期糖尿病妇女。
Pub Date : 1974-04-01
T S Danowski, S Nolan, T Stephan, H R Wilson, J W Vester, J H Sunder

The reduction of high serum LH levels toward or to normal in diabetic women in the menopausal range recorded during the first year of treatment with a synthetic progestin, 17-alpha-ethynyl-19-nortestosterone acetate, 3-cyclopentylenol ether (quingestanol acetate), was maintained during the second and third years of daily ingestion of this steroid. Normal LH and normal or high FSH levels prior to therapy were not affected. Other endocrine indices, including serum PBI and T4, plasma 11(OH) corticosteroids, serum growth hormone titers, insulin responses to oral glucose, and urinary excretion of 17-ketosteroids, Porter-Silber chromogens, and 11-desoxycortisol metabolites, estrogens, and creatinine remained relatively unchanged during quingestanol therapy. At the 36th month of treatment, a small increase in fasting blood glucose levels with greater hypoglycemia after oral carbohydrate was noted, but this probably reflected the natural history of treated diabetes mellitus. The decrease in urinary steroid responses to partial blockade of adrenal 11-beta hydroxylase by metyrapone observed in the 12th month of quingestanol therapy was not evident at the end of 24 and 36 months of treatment. Quingestanol therapy was associated with maintenance of the increase in serum sodium from low-normal to mid-normal concentrations noted during the first year of treatment. Serum chloride increases were less frequent. Other serum electrolytes, solutes, proteins and other nitrogenous constituents, lipids, and enzymes and formed blood elements generally fluctuated within the pre-therapy ranges. Body weight, blood pressure, pulse rate, electrocardiograms, and perception of vibrations were about the same prior to and at the completion of the three-year course of therapy. The steroid was well tolerated.

在使用合成黄体酮,17- α -乙基-19-去甲睾酮醋酸酯,3-环戊烯醇醚(醋酸喹estanol)治疗的第一年,记录的绝经期糖尿病妇女的高血清黄体生成素水平接近或恢复正常,在每天摄入这种类固醇的第二年和第三年保持不变。治疗前正常LH和正常或高FSH水平不受影响。其他内分泌指标,包括血清PBI和T4、血浆11(OH)皮质类固醇、血清生长激素滴度、胰岛素对口服葡萄糖的反应、17-酮类固醇、波特-希尔伯色素、11-去氧皮质醇代谢物、雌激素和肌酐的尿排泄,在喹estanol治疗期间保持相对不变。在治疗的第36个月,空腹血糖水平小幅升高,口服碳水化合物后低血糖更严重,但这可能反映了治疗后糖尿病的自然历史。在喹estanol治疗的第12个月,观察到美替拉酮部分阻断肾上腺11- β羟化酶后尿类固醇反应的下降,但在治疗的第24和36个月结束时并不明显。在治疗的第一年,青estanol治疗与维持血清钠从低正常浓度到中等正常浓度的增加有关。血清氯化物升高的频率较低。其他血清电解质、溶质、蛋白质和其他含氮成分、脂质、酶和形成的血液元素一般在治疗前的范围内波动。体重、血压、脉搏率、心电图和对振动的感知在三年疗程结束前和结束时基本相同。类固醇耐受性良好。
{"title":"Prolonged progestin (quingestanol) therapy of menopausal diabetic women.","authors":"T S Danowski,&nbsp;S Nolan,&nbsp;T Stephan,&nbsp;H R Wilson,&nbsp;J W Vester,&nbsp;J H Sunder","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The reduction of high serum LH levels toward or to normal in diabetic women in the menopausal range recorded during the first year of treatment with a synthetic progestin, 17-alpha-ethynyl-19-nortestosterone acetate, 3-cyclopentylenol ether (quingestanol acetate), was maintained during the second and third years of daily ingestion of this steroid. Normal LH and normal or high FSH levels prior to therapy were not affected. Other endocrine indices, including serum PBI and T4, plasma 11(OH) corticosteroids, serum growth hormone titers, insulin responses to oral glucose, and urinary excretion of 17-ketosteroids, Porter-Silber chromogens, and 11-desoxycortisol metabolites, estrogens, and creatinine remained relatively unchanged during quingestanol therapy. At the 36th month of treatment, a small increase in fasting blood glucose levels with greater hypoglycemia after oral carbohydrate was noted, but this probably reflected the natural history of treated diabetes mellitus. The decrease in urinary steroid responses to partial blockade of adrenal 11-beta hydroxylase by metyrapone observed in the 12th month of quingestanol therapy was not evident at the end of 24 and 36 months of treatment. Quingestanol therapy was associated with maintenance of the increase in serum sodium from low-normal to mid-normal concentrations noted during the first year of treatment. Serum chloride increases were less frequent. Other serum electrolytes, solutes, proteins and other nitrogenous constituents, lipids, and enzymes and formed blood elements generally fluctuated within the pre-therapy ranges. Body weight, blood pressure, pulse rate, electrocardiograms, and perception of vibrations were about the same prior to and at the completion of the three-year course of therapy. The steroid was well tolerated.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"25-30"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15570077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach to a combined pharmacologic therapy of childhood hyperkinesis. 儿童多动症的联合药物治疗方法探讨。
Pub Date : 1974-04-01
M Knobel

The pharmacologic management of childhood hyperkinesis with psychostimulants has repeatedly proved its efficacy. In the case of hyperkinesis with an organic background (with eviden electrocencephalographic signs), the association with different anticonvulsants is usually beneficial although at times it gives rise to exceptionally undesirable side-effects, or to a paradoxically depressant action of the psychic activity. A clinical trial was carried out in 30 children aged from 5 10 years, with 2-dimethylaminoethanol in association with a magnesium salt of dipropylacetic acid (DAP).

用精神兴奋剂治疗儿童运动亢进的药理学方法已多次证明其疗效。对于有器质性背景的运动亢进(有明显的脑电图征象),使用不同的抗惊厥药通常是有益的,尽管有时它会引起异常不良的副作用,或对精神活动产生矛盾的抑制作用。在30名5 - 10岁的儿童中进行了一项临床试验,2-二甲氨基乙醇与二丙基乙酸(DAP)镁盐联合使用。
{"title":"Approach to a combined pharmacologic therapy of childhood hyperkinesis.","authors":"M Knobel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The pharmacologic management of childhood hyperkinesis with psychostimulants has repeatedly proved its efficacy. In the case of hyperkinesis with an organic background (with eviden electrocencephalographic signs), the association with different anticonvulsants is usually beneficial although at times it gives rise to exceptionally undesirable side-effects, or to a paradoxically depressant action of the psychic activity. A clinical trial was carried out in 30 children aged from 5 10 years, with 2-dimethylaminoethanol in association with a magnesium salt of dipropylacetic acid (DAP).</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"87-90"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15721237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neurologist's use of rating scales, EEG, and tranquilizers in dealing with hysterical symptoms. 神经科医生在处理歇斯底里症状时使用评定量表、脑电图和镇定剂。
Pub Date : 1974-04-01
J Peters

This article is the result of an effort to help the neurologist deal with the hysterical patient on both a diagnostic and therapeutic level. The conclusion reached is that use of major tranquilizers may be needed to keep hysterical symptomatology under control while diagnostic investigation is proceeding and, if the diagnostic studies are negative, may be used to help ameliorate symptoms in patients unwilling to see a psychiatrist.

这篇文章是一个努力的结果,以帮助神经科医生处理歇斯底里的病人在诊断和治疗水平。得出的结论是,在进行诊断调查时,可能需要使用强效镇静剂来控制歇斯底里的症状,如果诊断研究呈阴性,则可用于帮助不愿看精神科医生的患者改善症状。
{"title":"The neurologist's use of rating scales, EEG, and tranquilizers in dealing with hysterical symptoms.","authors":"J Peters","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This article is the result of an effort to help the neurologist deal with the hysterical patient on both a diagnostic and therapeutic level. The conclusion reached is that use of major tranquilizers may be needed to keep hysterical symptomatology under control while diagnostic investigation is proceeding and, if the diagnostic studies are negative, may be used to help ameliorate symptoms in patients unwilling to see a psychiatrist.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"85-6"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15569767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rise in plasma free-norepinephrine during anesthetic induction with ketamine. 氯胺酮麻醉诱导时血浆游离去甲肾上腺素升高。
Pub Date : 1974-04-01
E K Zsigmond, R C Kelsch, S P Kothary

Mean plasma free-norepinephrine concentration rose significantly (p less than 0.001) during induction of anesthesia with intravenous ketamine (2.0 mg/kg) in 12 patients. In contrast, no change occurred during induction with thiamylal (5.0 mg/kg) in a control group of 8 patients. No significant rise in plasma free-epinephrine concentration occurred in either ketamine or thiamylal groups. These data support the suggestion that increased venous return mediated by the sympathetic nervous system may be responsible for the increased cardiac output and hypertension known to occur during ketamine anesthesia.

12例患者在静脉注射氯胺酮(2.0 mg/kg)诱导麻醉时,血浆游离去甲肾上腺素平均浓度显著升高(p < 0.001)。相比之下,在对照组8例患者中,硫氨酰(5.0 mg/kg)诱导未发生变化。氯胺酮组和硫胺酮组血浆游离肾上腺素浓度均未显著升高。这些数据支持由交感神经系统介导的静脉回流增加可能是氯胺酮麻醉期间发生的心输出量增加和高血压的原因。
{"title":"Rise in plasma free-norepinephrine during anesthetic induction with ketamine.","authors":"E K Zsigmond,&nbsp;R C Kelsch,&nbsp;S P Kothary","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mean plasma free-norepinephrine concentration rose significantly (p less than 0.001) during induction of anesthesia with intravenous ketamine (2.0 mg/kg) in 12 patients. In contrast, no change occurred during induction with thiamylal (5.0 mg/kg) in a control group of 8 patients. No significant rise in plasma free-epinephrine concentration occurred in either ketamine or thiamylal groups. These data support the suggestion that increased venous return mediated by the sympathetic nervous system may be responsible for the increased cardiac output and hypertension known to occur during ketamine anesthesia.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"81-4"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15569774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EEG spectrum analysis techniques applied to the problem of psi phenomena. 脑电图频谱分析技术在psi现象问题中的应用。
Pub Date : 1974-04-01
C S Rebert, A Turner

Electroencephalographic techniques were used to study unusual sensory capabilities. One S, the "sender," of a pair of Ss was stimulated with 10 sec duration trains of flicker at 6 or 16 fps, randomly interspersed with periods of no flicker. EEGs were recorded from another S, the "receiver," to determine if EEG driving or alpha block would be evident on trials when the sender was stimulated, compared to when the sender was not stimulated. Differential alpha block on control and stimulus trials was observed reliably in one receiver, indicating some information transfer. The S's overt indications of which stimulus occurred were not different from what would be expected by chance. The physical parameters by which the EEG effect was mediated were not determined.

脑电图技术被用来研究不寻常的感觉能力。一对S中的一个S,即“发送者”,被以每秒6帧或每秒16帧的速度连续10秒的闪烁刺激,随机穿插无闪烁的周期。从另一个S(“接收者”)记录脑电图,以确定当发送者受到刺激时,与发送者没有受到刺激时相比,脑电图驱动或α阻滞是否会在试验中明显。在同一受者中,对照和刺激试验中α阻滞的差异是可靠的,这表明存在信息传递。美国对刺激措施发生的公开迹象与偶然预期的并无不同。脑电效应介导的物理参数尚未确定。
{"title":"EEG spectrum analysis techniques applied to the problem of psi phenomena.","authors":"C S Rebert,&nbsp;A Turner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Electroencephalographic techniques were used to study unusual sensory capabilities. One S, the \"sender,\" of a pair of Ss was stimulated with 10 sec duration trains of flicker at 6 or 16 fps, randomly interspersed with periods of no flicker. EEGs were recorded from another S, the \"receiver,\" to determine if EEG driving or alpha block would be evident on trials when the sender was stimulated, compared to when the sender was not stimulated. Differential alpha block on control and stimulus trials was observed reliably in one receiver, indicating some information transfer. The S's overt indications of which stimulus occurred were not different from what would be expected by chance. The physical parameters by which the EEG effect was mediated were not determined.</p>","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"6 1-12","pages":"18-24"},"PeriodicalIF":0.0,"publicationDate":"1974-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15570075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. 棕榈酸哌嗪治疗住院及开放病房功能性精神病的临床体会。
Pub Date : 1973-10-01
C Salvesen, K Vaksdal
{"title":"Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.","authors":"C Salvesen,&nbsp;K Vaksdal","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"5 7-12","pages":"3-7"},"PeriodicalIF":0.0,"publicationDate":"1973-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15266801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thymometry: a technique for measuring feelings. 胸腺测量:一种测量感觉的技术。
Pub Date : 1973-10-01
R E Peck
{"title":"Thymometry: a technique for measuring feelings.","authors":"R E Peck","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"5 7-12","pages":"8-12"},"PeriodicalIF":0.0,"publicationDate":"1973-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15898360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Pernicious" fatigue--identification, pathogenesis, and treatment. “恶性”疲劳——鉴别、发病机制和治疗。
Pub Date : 1973-10-01
P L Kaye
{"title":"\"Pernicious\" fatigue--identification, pathogenesis, and treatment.","authors":"P L Kaye","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8769,"journal":{"name":"Behavioral neuropsychiatry","volume":"5 7-12","pages":"24-9, 31"},"PeriodicalIF":0.0,"publicationDate":"1973-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15898359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Behavioral neuropsychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1